콘텐츠로 건너뛰기
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Menu
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Get In Touch

Prime Minister Kim Boo-kyum visited the booth of PharmCADD in BIO KOREA 2021

<View Original Article>

Prime Minister Kim Boo-kyum visited the booth of PharmCADD in BIO KOREA 2021 더 읽기"

[ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation.

[ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation. 더 읽기"

PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards.

<View Original Article>

PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards. 더 읽기"

South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO.

<View Original Article>

South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO. 더 읽기"

PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect.

<View Original Article>

PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect. 더 읽기"

PharmCADD Raised $16M in Series B Funding.

<View Original Article>

PharmCADD Raised $16M in Series B Funding. 더 읽기"

Eyegene published a nonclinical paper COVID-19 vaccine on BioRxiv.

<View Original Article>

Eyegene published a nonclinical paper COVID-19 vaccine on BioRxiv. 더 읽기"

PharmCADD showed AI drug development platform, Pharmulator at AI EXPO in korea.

<View Original Article>

PharmCADD showed AI drug development platform, Pharmulator at AI EXPO in korea. 더 읽기"

PharmCADD provided scholarship to the Department of Physics at Pukyong National University

<View Original Article>

PharmCADD provided scholarship to the Department of Physics at Pukyong National University 더 읽기"

[New drug development using AI] Molecular design using generative models

<View Original Article>

[New drug development using AI] Molecular design using generative models 더 읽기"

← 이전 1 … 11 12 13 … 17 다음 →
Headquarters

Address : 224, Engineering Building 7, Sinseon-Ro 365, Namgu, Busan 48548, Republic of Korea
Call : 82-51-747-5681 | Fax : 82-51-747-5682

Seoul Office

Address : 1735, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, Republic of Korea
Call : 82-2-564-5688 | Fax : 82-2-564-5685

E-Mail : [email protected]
Call : 82-51-747-5681
Linkedin-in Youtube

© 2021 PharmCADD. All Rights Reserved.